Skip to main content
logo
Heidelberg Pharma AG (ETR:HPHA)
Germany flag Germany · Delayed Price · Currency is EUR
2.540
-0.060 (-2.31%)
Aug 5, 2026, 5:35 PM CET

Heidelberg Pharma AG Revenue

Heidelberg Pharma AG had revenue of 4.34M EUR in the quarter ending May 31, 2026, with 3,566.19% growth. This brings the company's revenue in the last twelve months to 7.45M, up 77.97% year-over-year. In the fiscal year ending November 30, 2025, Heidelberg Pharma AG had annual revenue of 1.46M, down -78.72%.

Revenue (ttm)
7.45M
Revenue Growth
+77.97%
P/S Ratio
15.96
Revenue / Employee
181.59K
Employees
41
Market Cap
118.83M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Nov 30, 20251.46M-5.39M-78.72%
Nov 30, 20246.85M-3.01M-30.53%
Nov 30, 20239.86M-8.66M-46.75%
Nov 30, 202218.51M16.48M810.30%
Nov 30, 20212.03M-6.63M-76.53%
Nov 30, 2020 Pro Pro Pro
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bayer Aktiengesellschaft45.38B
Siemens Healthineers AG23.17B
Fresenius SE & Co. KGaA22.99B
Merck KGaA20.96B
Medios AG2.12B
MEDICLIN Aktiengesellschaft819.84M
Stratec SE243.93M
DocCheck AG55.32M
Revenue Rankings

Heidelberg Pharma AG News

More News